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Abstract 
Due to their ability in self-renewing and differentiation into a wide variety of tissues, 
mesenchymal stem cells (MSCs) exhibit outstanding potential for regenerative medicine. This 
study was aimed at investigating different aspects of MSC therapy in controlling hyperglycemia 
in streptozotocin-induced diabetes rats. Using an islet cell differentiation protocol, bone marrow 
(BM) MSCs were differentiated into insulin-producing cells (IPCs). The differentiation process 
was evaluated by immunocytochemistry, reverse transcriptase PCR, and dithizone staining. 
Diabetic animals in 4 diabetic individual groups received normal saline, BM-MSCs, 
coadministration of BM-MSCs with supernatant, and IPCs. Blood glucose and insulin levels 
were monitored during the experiment. Immunohistochemical analysis of the pancreas was 
performed at the end of the experiment. Administration of BM-MSCs could not reverse glucose 
and insulin levels in experimental animals as efficiently as cotransplantation of BM-MSCs with 
supernatant. The effect of coadministration of BM-MSCs with supernatant and transplantation of 
IPCs on controlling hyperglycemia is comparable. Immunohistochemical analysis showed that 
number and size of islets per section were significantly increased in groups receiving IPCs and 
BM-MSC-supernatant compared to the MSC group of animals. In conclusion, coadministration 
of BM-MSCs with supernatant could be used as efficiently as IPC transplantation in controlling 
hyperglycemia in diabetic rats. 
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